Status:
COMPLETED
Evaluating the Adherence Improving Self-Management Strategy Intervention in Chronic Heart Failure Patients
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Canisius-Wilhelmina Hospital
Maas Hospital Pantein
Conditions:
Chronic Heart Failure
Heart Decompensation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patient non-adherence to treatment recommendations is common and decreases the effectiveness of Chronic Heart Failure (CHF) treatment. Improving adherence towards medication intake, physical activity,...
Detailed Description
◦Quality assurance plan that addresses data validation and registry procedures, including any plans for site monitoring and auditing. Data for the primary outcome medication adherence will be monitor...
Eligibility Criteria
Inclusion
- Diagnosed with Chronic Heart Failure (from either preserved or non-preserved systolic functions)
- New York Heart Association class II and III
- Able to understand and perform study related procedures
- Has an appointment at the HF clinic of at least once per 6 months
Exclusion
- Unable to give informed consent
- New York Heart Association class I or IV
- Participation in another interventional study targeting medication adherence, physical activity, symptom monitoring, and/or diet.
- A coexisting imminently terminal illness, such as cancer or chronic renal failure requiring dialysis.
- Patients in titration phase (due to multiple changes in medication regimen)
Key Trial Info
Start Date :
December 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 24 2023
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT04698954
Start Date
December 14 2020
End Date
February 24 2023
Last Update
June 15 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525 GA
2
CWZ
Nijmegen, Gelderland, Netherlands, 6532 SZ
3
Maasziekenhuis Pantein
Beugen, North Brabant, Netherlands, 5835 DV